Cronos Group Inc
NASDAQ:CRON
Cronos Group Inc
NASDAQ:CRON
Price:
2.44
USD
-2.4%
Market Closed
Market Cap:
$932.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cronos Group Inc
NASDAQ:CRON
|
CA |
|
Thai Beverage PCL
OTC:TBVPF
|
TH |
|
G
|
General Commercial and Industrial SA
ATHEX:GEBKA
|
GR |
|
Pet Valu Holdings Ltd
TSX:PET
|
CA |
|
GMO Pepabo Inc
TSE:3633
|
JP |
|
Industria de Diseno Textil SA
OTC:IDEXY
|
ES |
|
F
|
Ffbw Inc
OTC:FFBW
|
US |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
Baioo Family Interactive Ltd
HKEX:2100
|
CN |
|
Eastman Chemical Co
NYSE:EMN
|
US |
|
Guardant Health Inc
NASDAQ:GH
|
US |
Multiples-Based Value
The Multiples-Based Value of one
CRON
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 2.44 USD,
Cronos Group Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRON Multiples-Based Value
LOCKED
Multiples Across Competitors
CRON Competitors Multiples
Cronos Group Inc Competitors
Cronos Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Cronos Group Inc
NASDAQ:CRON
|
1.3B USD | 6.6 | -103.1 | -357.3 | -9.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.9B CHF | 5.3 | 21.4 | 13.2 | 17 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
